Tetra Radar · FDA Approvals · Decision date
Moderna Inc: FDA decision date
Moderna Inc (MRNA) · 5 August 2026
The FDA has assigned a PDUFA date for mRNA-1010 of August 5, 2026.
Source: 10-Q of 31 July 2026
The FDA approved it on 5 August 2026.
The FDA approved MFLUSIVA for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B represented in the vaccine in persons 50 years of age and older.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.